AI assistant
Neuland Laboratories Limited. Capital/Financing Update 2021
62255_rns_2021-07-29_84f7f4b5-e147-42c0-84d3-ab9cbd86dbcf.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Neuland Laboratories Limited 11th Floor (5th Office Level), Phoenix IVY Building, Plot No.573A-11I, Road No.82, Jubilee Hills, Hyderabad - 500033, Telangana, India.
Tel: 040 67611600 / 67611700 Email: [email protected] www.neulandlabs.com
July 29, 2021
To BSE Limited Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai - 400 001
To The National Stock Exchange of India Ltd Exchange Plaza, Sandra Kurla Complex, Bandra (E) Mupmbai - 400 001
Scrip Code: 524558
Scrip Code: NEULANDLAB; Series: EQ
Dear Sirs,
Results Release and Earnings Call Notice
We refer to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015 and enclose a copy of the Q1 FY 2021-2022 Earnings Call details, for your information and records.
Thanking you,
Yours faithfully, For Neula s Limited
-»4,, Sarada Bha ~i ,- ~~.....- Company Secretary
Encl: As above
Neuland Laboratories Limited's Q1FY22 Results Conference Call At 17:00 hrs. IST on August 3, 2021
Neuland Laboratories Limited will announce its results for the first quarter ended June 30, 2021 on August 3, 2021. The results will also be made available on the website of the Company, www.neulandlabs.com
Following the announcement, the management of the Company will host an Earnings Call on Aug 3, 2021 at 17:00 hrs. The details of the earnings call are:
Date: Aug 3, 2021
Time: 17:00 Hrs
For Zoom Link Registration Please Click Here:
Zoom Link
About Neuland Laboratories Limited (BSE:524558, NSE: NEULANDLAB)
For over 37 years, Neuland Labs has been at the forefront of manufacturing APIs through its cGMP manufacturing facilities, working with customers in close to 80 countries. Neuland Labs has developed more than 300 processes and 75 APIs and has filed 57 active US DMFs, and in other geographies. Its manufacturing facilities are inspected and approved by the U.S. FDA and other leading regulatory agencies. Its record of quality manufacturing and reliability is highlighted by cGMP certifications that include the U.S. FDA, TGA (Australia), EDQM (EU), German Health Authority, ANVISA (Brazil), EMA (EU), Cofepris (Mexico), KFDA (Korea), PMDA (Japan), CFDA (China), FSI "SID &GP" Russia, Health Canada, ISO 9001, ISO14001, OHSAS18001 and ISO 27001.
For more information, visit www.NeulandLabs.com.
For more queries please contact: